Hippocratic AI becomes first healthcare AI enterprise delivering clinical digital agents to collaborate with leading global professional services organization KPMG, to reimagine patient care through holistic organizational transformations.

London, UK – July 8, 2025 – Today KPMG International announces its innovative and timely work with healthcare technology company Hippocratic AI, global leader in developing safety-first generative AI healthcare agents that work alongside healthcare workers, performing non-diagnostic clinical tasks for patients.

The international healthcare sector is experiencing a significant workforce shortage, with projections indicating a shortfall of approximately 10 million health workers by 2030. To help address this and relieve backlogs in healthcare systems worldwide, Hippocratic AI’s generative AI agents safely conduct non-diagnostic patient-facing clinical tasks marking a major milestone in addressing the global workforce shortage. KPMG’s global healthcare professionals are collaborating with Hippocratic AI to reimagine care delivery to support today’s constrained healthcare workforce and create more efficient operational processes, ultimately alleviating overload on the workforce and improving patient outcomes. More specifically, KPMG is conducting broad process analyses to identify high-pressure points and upskill workforces to help best augment the workforce with AI and strategically plan for the highest impact deployment of AI across the entire care continuum.

Hippocratic’s generative AI agents can free up provider time to focus on their patients using conversational agents designed to interact with humans in a natural intuitive way as the agents comprehend, process, and respond to human conversation in a contextually relevant and human-like manner. Hippocratic AI’s work represents a paradigm shift in how care is administered, signifying a move toward more abundant healthcare. Powered by its patented Polaris Constellation architecture, which features specialized large language support models, the generative AI healthcare agents can deliver a range of healthcare workflows from patient intake to care management follow up calls. KPMG firms support by conducting broad process analyses to identify high-pressure points and upskill workforces to ensure human-AI alignment. This exercise enables KPMG firms to strategically plan the deployment of AI across the entire care continuum, effectively managing potential disruptions to achieve maximal value in productivity and patient outcomes.

“Hippocratic AI's collaboration with KPMG is deeply aligned in purpose and vision. Their holistic approach to digital and clinical transformation focuses on improving patient outcomes and optimizing healthcare efficiency. We appreciate their commitment to driving meaningful impact across the entire care journey with generative AI, while preserving the human touch of clinicians and the integrity of healthcare operations,” said Munjal Shah, Founder and CEO of Hippocratic AI.

 “As societies age, we are facing a critical healthcare workforce shortage that endangers the continuity of care. Hippocratic AI’s generative AI healthcare agents can address such risks, however, to unlock their full value, a coherent and robust approach is needed to transform operational processes and upskill and empower clinical staff so the human workforce and their AI agent colleagues can operate in concert,” said Dr. Anna van Poucke, KPMG Global Healthcare Leader.

We have always thought that Hippocratic AI could benefit all sectors of healthcare worldwide and the tremendous success of the launch of our Gen AI agents among North American healthcare providers, clinicians, and patients, as well as our recent announcements in the UAE, Japan, and UK are strong indicators that we are on that path.

Munjal Shah, Founder, and CEO of Hippocratic AI

For more information, contact:

Daniel Caines
Senior Manager, External Communications
KPMG International

T: +44 7732400262 
E: daniel.caines@KPMG.co.uk

About Hippocratic AI

Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, https://www.hippocraticai.com

About KPMG International

KPMG is a global organization of independent professional services firms providing Audit, Tax and Advisory services. KPMG is the brand under which the member firms of KPMG International Limited (“KPMG International”) operate and provide professional services. “KPMG” is used to refer to individual member firms within the KPMG organization or to one or more member firms collectively. 

KPMG firms operate in 143 countries and territories with more than 275,000 partners and employees working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such. Each KPMG member firm is responsible for its own obligations and liabilities. 

KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients. 

For more detail about our structure, please visit kpmg.com/governance. 

Dr. Anna van Poucke

Global Head of Healthcare, KPMG International, and Healthcare Senior Partner

KPMG in the Netherlands